Literature DB >> 32847887

Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia.

Osama Mosalem1,2, Fawzi Abu Rous3,4, Ahmed Elshafie3,2, Daniel Isaac5.   

Abstract

Here we describe a 27-year-old woman, 5 months post partum, who presented to the emergency department with bilateral breast masses. She was initially treated as lactational mastitis with no improvement. Breast ultrasound showed bilateral breast and axillary lymphadenopathy suggestive of metastatic/neoplastic process, and chest X-ray showed a large anterior mediastinal mass. Further work-up led to the diagnosis of T-cell acute lymphoblastic leukaemia. The patient was started on a paediatric regimen using the children's oncology group AALL0434 protocol. The patient achieved a complete remission following induction chemotherapy with resolution of her presenting symptoms. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  breast cancer; cancer intervention; chemotherapy; malignant disease and immunosuppression

Mesh:

Year:  2020        PMID: 32847887      PMCID: PMC7451470          DOI: 10.1136/bcr-2020-236263

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Bilateral breast involvement in acute myelogenous leukemia.

Authors:  N J Khoury; F M Hanna Al-Kass; H N Jaafar; A T Taher; A I Shamseddine
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 2.  T-cell acute lymphoblastic leukemia.

Authors:  Sabina Chiaretti; Robin Foà
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

Review 3.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

Review 4.  Acute leukemia presenting with extramedullary diseases and completely normal hemogram: an extremely unusual manifestation unique to pre-B ALL.

Authors:  Chih-Cheng Chen; Hsu-Huei Weng; Cih-En Hwang; Chang-Hsien Lu; Ping-Tsung Chen; Jyh-Pyng Gau
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

5.  Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).

Authors:  Michael E Rytting; Deborah A Thomas; Susan M O'Brien; Farhad Ravandi-Kashani; Elias J Jabbour; Anna R Franklin; Tapan M Kadia; Naveen Pemmaraju; Naval G Daver; Alessandra Ferrajoli; Guillermo Garcia-Manero; Marina Y Konopleva; Jorge E Cortes; Gautham Borthakur; Rebecca Garris; Maria Cardenas-Turanzas; Kurt Schroeder; Jeffrey L Jorgensen; Steven M Kornblau; Hagop M Kantarjian
Journal:  Cancer       Date:  2014-07-17       Impact factor: 6.860

6.  Breast leukemia: an update.

Authors:  Alexey Surov; Andreas Wienke; Jasmin Abbas
Journal:  Acta Radiol       Date:  2012-04-01       Impact factor: 1.990

Review 7.  Prognostification of ALL by Cytogenetics.

Authors:  Ansar Hakeem; Aejaz Aziz Shiekh; Gull Mohd Bhat; A R Lone
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

8.  An autopsy study of the metastatic patterns of human leukemias.

Authors:  E Viadana; I D Bross; J W Pickren
Journal:  Oncology       Date:  1978       Impact factor: 2.935

9.  Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Authors:  Kimberly P Dunsmore; Stuart S Winter; Meenakshi Devidas; Brent L Wood; Natia Esiashvili; Zhiguo Chen; Nancy Eisenberg; Nikki Briegel; Robert J Hayashi; Julie M Gastier-Foster; Andrew J Carroll; Nyla A Heerema; Barbara L Asselin; Karen R Rabin; Patrick A Zweidler-Mckay; Elizabeth A Raetz; Mignon L Loh; Kirk R Schultz; Naomi J Winick; William L Carroll; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2020-08-19       Impact factor: 44.544

Review 10.  L-asparaginase in the treatment of patients with acute lymphoblastic leukemia.

Authors:  Rachel A Egler; Sanjay P Ahuja; Yousif Matloub
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.